How Wazoku Crowd Solved Challenges in Dermatology

Transforming Dermatology with Wazoku’s Open Innovation Platform

The field of dermatology faces a wide range of challenges, from diagnosing complex skin conditions to developing innovative treatments for chronic diseases like eczema, psoriasis, and acne. At Wazoku, we empower organizations to solve these problems through our Open Innovation Platform, connecting them with a global network of experts and innovators. This collaborative approach has enabled breakthroughs in dermatology, from non-invasive diagnostic methods for hyper-pigmentation to patient-centric support services for those suffering from psoriasis.

On this page, you’ll discover how Wazoku Crowd has tackled dermatology’s toughest challenges, providing solutions that enhance patient care, streamline treatments, and introduce new therapeutic approaches. Whether it’s repurposing drugs for eczema, creating new acne treatments, or developing support services for psoriasis patients, Wazoku’s open innovation platform is helping to revolutionize dermatology.

Developing a Non-Invasive Diagnostic Method for Facial Hyper-Pigmented Spots

Facial hyper-pigmentation, a condition where areas of the skin darken due to excess melanin, can manifest in various forms, such as solar lentigo (age spots), freckles, melasma, and seborrheic keratosis. Each type of hyper-pigmentation requires a unique treatment, but the current diagnostic standard—skin biopsies—are invasive, painful, and slow.

To address this, the Seeker launched a challenge through Wazoku’s Open Innovation platform, aiming to find a non-invasive diagnostic method that can quickly and accurately differentiate between types of hyper-pigmented spots.

The challenge encouraged innovative ideas for a method that could:

• Be non-invasive: No skin biopsies; simple touching or tape stripping would be acceptable.
• Provide rapid results: Ideally within one minute, with diagnostic analysis completed in a few minutes or hours.
• Offer a reliable and accurate diagnosis for each type of spot.

How the Wazoku Crowd Solved It: Through Wazoku’s platform, solvers proposed novel techniques, including advanced digital imaging systems, AI-powered tools, and non-invasive scanning devices capable of identifying the biological differences in facial hyper-pigmented spots. These methods promised rapid, painless diagnosis while maintaining accuracy.

These innovative solutions could revolutionize the way hyper-pigmentation is diagnosed and treated, offering dermatologists faster and more effective tools in clinical practice.

Explore More: Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Repurposing Opportunities for the Treatment of Eczema

Eczema, a chronic skin condition affecting millions worldwide, is characterized by inflammation, itchiness, and dry skin, with treatments often limited by side effects or lack of long-term efficacy. While current options like corticosteroids and immunosuppressants offer relief, they can lead to adverse effects with prolonged use, creating a need for safer alternatives.

To address this, the Seeker, a research-based pharmaceutical company, launched a dermatology challenge through Wazoku’s Open Innovation platform to identify repurposing opportunities for existing drugs or molecules that could be effective in treating eczema. The goal was to find compounds that may already be approved for other conditions but could be repositioned for eczema, particularly for atopic dermatitis.

The challenge sought solutions that:

• Repurpose an existing drug or molecule: Preferably one that is off-patent or in late-stage clinical trials.
• Demonstrate therapeutic benefit: The drug should help improve the skin barrier, reduce inflammation, or prevent flare-ups.
• Prefer topical application: Minimizing systemic side effects while targeting affected areas.

How the Wazoku Crowd Solved It: Through Wazoku’s platform, solvers identified novel compounds that could be repurposed for eczema treatment, many of which exhibited anti-inflammatory properties or skin barrier-repair capabilities. Solutions ranged from off-patent drugs used in unrelated diseases to innovative drug combinations demonstrating synergistic effects for eczema.

These proposals provided the Seeker with promising alternatives to current treatments, leveraging existing drugs in a new context to improve the management of eczema with fewer side effects.

Explore More: Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Novel Treatment Approaches to Acne

Acne affects nearly 10% of the global population, causing not only physical discomfort but also emotional distress due to scarring and blemishes. While current treatments—such as benzoyl peroxide, salicylic acid, and antibiotics—provide relief, they often have limitations in terms of efficacy, side effects, and convenience, especially for those with moderate to severe acne.

To address these shortcomings, the Seeker launched a dermatology challenge through Wazoku’s Open Innovation platform, calling for novel treatment solutions that improve on existing therapies. This includes repurposed drugs, new formulations, and innovative devices that target acne in a more effective, safe, and tolerable manner.

The ideal solution should:

• Improve efficacy: Offer better results, especially for moderate to severe cases.
• Enhance safety and skin tolerability: Reduce common side effects like irritation or inflammation.
• Offer a more convenient regimen: With a preference for topical or oral applications.
• Target the sebaceous glands, where acne develops.

How the Wazoku Crowd Solved It: Wazoku’s global community of solvers responded with a wide range of innovative ideas, from novel drug combinations and topical formulations to repurposed treatments originally used for other conditions. Some solutions focused on reducing inflammation and sebum production, while others aimed at improving the skin’s ability to heal and prevent scarring.

These proposals provided the Seeker with new approaches to managing acne, offering safer, more effective alternatives that could enhance the quality of life for patients around the world.

Explore More: Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Creating Stellar Support Services for Psoriasis Patients

Psoriasis, the most common autoimmune disease in the U.S., affects millions of patients with painful, disfiguring, and socially isolating symptoms. While biologic treatments have made strides in managing the disease, psoriasis patients often face challenges related to medication adherence, emotional distress, and lack of adequate support services. For many, navigating these challenges adds to their frustration, particularly when their prescribed therapies fail to meet expectations.

To address this, the Seeker launched a dermatology Challenge through Wazoku’s Open Innovation platform to create best-in-class patient support services for a new biologic product targeting psoriasis. The aim was to deliver seamless support that enhances patient experiences while being easy to use and not burdensome for healthcare providers.

The ideal support service should:

• Improve patient acquisition: Provide accessible educational resources and clear communication.
• Ensure smooth product delivery: Help patients navigate reimbursement, learn self-injection techniques, and access financial support.
• Enhance patient retention: Offer reminders and emotional support to improve adherence and overall well-being.
• Deliver exceptional customer service: Create a personalized experience that sets the service apart from competitors in the pharmaceutical industry.

How the Wazoku Crowd Solved It: Wazoku’s solvers proposed innovative strategies to improve the psoriasis patient journey. These solutions integrated educational tools, personalized care plans, and emotional support networks, ensuring that patients not only adhered to their treatments but also felt supported throughout their experience. With a focus on best-in-class customer service, the proposals provided a differentiated, value-added approach to psoriasis care.

These comprehensive support services promise to improve patient outcomes, strengthen patient-provider relationships, and position the new product as a leader in the psoriasis market.

Explore More: Learn more about this challenge and others on Wazoku’s Open Innovation Challenge Centre.

Wazoku Open Innovation

Wazoku’s Open Innovation platform has proven to be a powerful tool for solving complex challenges. By bringing together a global community of solvers, Wazoku helps leading organizations in the Health and Life Sciences industry tackle their toughest problems, drive innovation, and improve patient outcomes.

Whether through cutting-edge technologies like AI, precision medicine, or patient-centered research, Wazoku Crowd continues to push the boundaries of what’s possible in healthcare innovation.

Interested in driving innovation for your organization?

Run your own challenge and unlock the power of global collaboration to solve your toughest problems.

Explore